HealthcareServices

Global Genotyping Assay Market Report 2026: Emerging Trends and Growth Scenarios

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genotyping assay market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Genotyping Assay Market by the end of 2030?

The genotyping assay market has demonstrated exponential growth in its size during recent years. This market is projected to expand from $41.31 billion in 2025 to $50.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.1%. Historically, this growth has been fueled by the development of pcr techniques, the growth of molecular diagnostics, pharmaceutical safety testing needs, early assay commercialization, and academic research demand.

The genotyping assay market size is anticipated to undergo significant expansion over the next few years, projected to reach $116.09 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 22.9%. This growth throughout the forecast period stems from factors such as increased biomarker-driven drug development, enhanced automation in laboratories, the broadening use of companion diagnostics, a higher demand for rapid assays, and regulatory validation. Prominent trends observed during this period include a rising demand for SNP-based assays, greater adoption of PCR-based genotyping, the emergence of high-sensitivity genotyping assays, expanded applications of genotyping assays in drug development, and the integration of automation into assay processing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

What Drivers Are Shaping Future Opportunities In The Genotyping Assay Market?

The rising occurrence of genetic disorders is anticipated to fuel the expansion of the genotyping assay market in the future. These conditions refer to medical issues resulting from abnormalities or changes in an individual’s deoxyribonucleic acid (DNA). Genotyping assays work by comparing the DNA of affected individuals with that of healthy ones to identify alterations, thereby uncovering specific genetic mutations or variations associated with a given genetic disorder. For instance, in June 2023, Gene People, a UK-based registered charity organization dedicated to supporting individuals with genetic conditions, stated that in the UK, one in every 25 children suffered from a genetic disorder. This impacted approximately 30,000 newborns and young children in the country, along with more than 2.4 million children and adults annually. Consequently, the growing prevalence of genetic disorders is propelling the growth of the genotyping assay market.

Which Segment Groups Are Influencing The Genotyping Assay Market?

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits

2) By Genotyping Services: Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

3) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

4) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

Which Trends Are Expected To Influence The Genotyping Assay Market In The Upcoming Years?

Leading companies in the genotyping assay market are making progress in genomic research, exemplified by the development of CE-IVD certified assays to detect HIV-1 strains resistant to treatment. The CE-IVD compliant Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit is a Sanger sequencing-based assay that analyzes positive human immunodeficiency virus (HIV) samples to identify genetic variations potentially causing resistance to common antiretroviral therapies. For example, in January 2023, Thermo Fisher Scientific, a US-based company, introduced the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system is capable of detecting treatment-resistant HIV-1 strains and features unique capabilities such as assessing genomic mutations, utilizing HIV RNA, identifying drug resistance mutations, employing gold-standard Sanger sequencing technology, and is intended for clinical use. The release of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has brought value by improving the detection of drug-resistant HIV-1 strains, providing convenient ready-to-use reagents and controls, adhering to regulatory requirements, demonstrating high-performance qualities, and ensuring compatibility with existing sequencing platforms and workflows.

Who Are The Prominent Global Companies Shaping The Genotyping Assay Market Landscape?

Major companies operating in the genotyping assay market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Which Region Is Projected To Lead The Genotyping Assay Market During The Forecast Period?

North America was the largest region in the genotyping assay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genotyping Assay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

Browse Through More Reports Similar to the Global Genotyping Assay Market 2026, By The Business Research Company

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genotyping Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Reporter Gene Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/reporter-gene-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795